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Ethics should always be the primary 
concern regarding any research that involves 
human experimentation. Yet, in the Tuskegee 
Study (1), we see the consequences of 40 years of 
unregulated human experimentation violating 
any degree of ethical standards. This experiment 
was unethical from the start, as the potential 
knowledge that could have been gained from 
the experiment would not have been useful 
in treating patients in the future; all the 
experiment accomplished was risking the lives 
of and causing immense suffering to hundreds 
of patients with no possible medical benefit. 
Furthermore, the experiment completely lacked 
informed consent and instead, the Public Health 
Service or PHS (1) took advantage of the racial 
and socioeconomic status of the Macon County 
community to manipulate the uneducated 
population into agreeing to the study. Once 
word of the study spread throughout the 
scientific community, a few critics brought the 
moral and scientific flaws to light. However, 
since the study was regulated by the PHS, 
which was the same organization running the 
study staffed by members who had been part 
of the study for years, these major problems 
were overlooked, and the study was allowed to 
continue for many decades. These major aspects 
of the Tuskegee study demonstrate the need for 
serious ethical regulation regarding any medical 
study regarding humans and provide insight on 
how this should be done in the future.
Opinion concerning the ethics of 
the Tuskegee experiment and human 
experimentation in general varies drastically, 
which is part of why universal ethical standards 
are difficult to define. Some experts defend the 
Tuskegee experiment from an ethical standpoint 
and justify withholding treatment of syphilis 
with the other types of medical care patients got 
instead and the risky nature of chemotherapy in 
the early years. Nurse Eunice Rivers, who was 
directly involved with bridging the gap between 
doctors and patients, justifies withholding 
treatment by claiming that the harmful effects of 
the early treatment were too severe, and that the 
patients received many other medical benefits 
to compensate for their lack of treatment. 
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Figure 1: A doctor draws blood 
from one of the Tuskegee test 
subjects. 
Source: Wikimedia Commons 
(Credit: National Archives)
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She says, “I saw so many reactions with these 
medications[Neoarsphenamine and bismuth]… 
I didn’t feel good about neo and all this stuff ” 
(1). As James Jones, the author of Bad Blood, 
states, even if Nurse Rivers truly believed in this 
justification due to the potentially harmful side 
effects of early treatment, the argument falls 
apart when applied to withholding penicillin. 
In order to rationalize the later years of her 
involvement in the study, Rivers states, “They 
didn’t get treatment for syphilis, but they got so 
much else,” referring to the medical care they got 
from doctors regularly checking up on them and 
giving them free aspirin and “spring tonic” for 
their aches and pains (1). Dr. Heller, who was Dr. 
Vonderlehr’s successor as director of Division of 
Venereal Diseases, justifies continuing the study 
even with the advent of penicillin by stating 
“The longer the study, the better the ultimate 
information we would derive,” and looking back 
he does feel that the experiment was unethical 
but also believes it is not comparable to the 
Nuremberg trials (1).
On the other side of the spectrum, many 
experts believe that the Tuskegee study was 
immoral and have different notions of what 
makes a human experiment ethical. The first 
doctor to object to the ethics of the study was 
Dr. Irwin J. Schatz of Henry Ford Hospital 
who sent a letter to the author of an article 
on the study saying, “I am utterly astounded 
by the fact that physicians allow patients with 
a potentially fatal disease to remain untreated 
when effective therapy is available… I suggest 
that the[PHS doctors]… reevaluate their 
moral judgements…” (1). Schatz expresses his 
disapproval of withholding treatment from the 
men in the study due to moral concerns and 
was the first to do so by 1965, 23 years after the 
study begun. Another expert who opposes the 
study is Peter Buxtun, an investigator born to 
parents who fled Europe from the Nazis. Due 
to his background, Buxtun was able to draw 
the connection between the Nuremberg trials 
of the Nazis to the Tuskegee experiment and 
expressed to coworkers that “It [the Tuskegee 
study] didn’t sound like what a PHS institution 
should be doing” (1). Buxtun expressed “grave 
moral concerns about the experiment” and 
pointed out the lack of informed consent by 
saying, “they were nothing more than dupes 
and were being used as human substitutes for 
guinea pigs” (1). Many modern experts also have 
similar opinions on human studies in general, 
including Dr. Marcia Angell, executive editor 
of The New England Journal of Medicine, and 
Marc Lallemant, an investigator from Harvard, 
who openly express their opinions against using 
“dummy pills” for a more recent AIDS studies 
in third world countries (2). The Physicians 
Committee for Responsible Medicine (3) also 
emphasizes the importance of taking morality 
seriously in any human experiment (3).
From the wide expert opinions on medical 
ethics, I would agree with Dr. Schatz, Peter 
Buxtun, and the Physicians Committee for 
Responsible Medicine that the morality of 
an experiment involving humans must be 
considered seriously. I feel that Dr. Schatz and 
Buxtun were completely correct for expressing 
their concerns to the PHS even at the risk of their 
careers, and that whistleblowers in the medical 
community should be commended for their 
actions. On the other hand, I completely disagree 
with Nurse Rivers’ and Dr. Heller’s opinions on 
the experiment, and I was disgusted by Heller’s 
absolute disregard for the wellbeing of the 
patients and Rivers’ delusional rationalization 
that she was helping the men by conducting 
the study. I believe that both Rivers and Heller 
should have their medical licenses and awards 
revoked due to their failure to practice medicine 
ethically under the Hippocratic Oath-- this 
would simultaneously serve as a form of justice 
as well as set an example for future practitioners 
of medicine. Regarding the placebo pills in third 
world countries, I believe that their usage is 
not nearly as unethical a practice as lying to 
patients with a fatal disease about treatment, 
but it should be required to test prototype 
drugs against the current standards instead of 
placebos. Since governments subsidize these 
experiments in the third world, it should be 
their responsibility to find the funding for 
these tests instead of putting the burden on the 
pharmaceutical companies.
In order to ameliorate the condition of 
human medical research, I think that human 
experimentation needs to be heavily regulated 
to ensure that it is kept within the bounds of 
current ethical standards. I would define these 
standards to include a need for informed and 
voluntary consent of the subjects, as well as 
a clear potential benefit that could improve 
humanity significantly enough to justify the 
potential risks on the subjects. In order to create 
and enforce these regulations, the government 
may need to create an organization purely to 
pass and enforce laws regarding this issue. This 
organization should not engage in research 
itself as this would make proper enforcement 
of ethical standards impossible, which is exactly 
what happened with the PHS’s attempt to 
assess itself during the Tuskegee study. The 
organization should be publicly open about its 
actions in order to allow for the general public 
to help determine what is ethical. This should 
also be brought up to an international level so 
that ethical standards can be kept consistent 
across the globe.
The first step in attaining ethical standards 
in medical experiments on humans is to define 
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standards should be the voluntary and informed 
consent of participants in the study. This means 
that subjects of the experiment should not be 
pressured to join or taken advantage of due 
to their racial, socioeconomic, or any other 
type of status. Instead, researchers should seek 
volunteers who understand the risks of the 
study and agree to partake in the study. This also 
should be common sense since it is never ethical 
to forcefully impose health risks on another 
person without their agreement to it. Like the 
first requirement, the need for informed consent 
was also not met during the Tuskegee study, as 
the uneducated, poor, and historically neglected 
black population of Macon County was an 
easy target for deceit. Similarly, the National 
Academy of Sciences revealed in 1993 that the 
U.S. military had been conducting chemical 
weapons tests from 1944 to 1977 on thousands 
of American GIs and radiation tests on over 
two hundred thousand civilians all without 
their informed consent (3). These practices are 
not morally acceptable and call for the need 
of informed consent. These two principles of 
ethics must be taken into account whenever 
conducting human experiments and should 
be incorporated into legal policies governing 
medical research.
Once regulatory policy is built based on 
these requirements, a government organization 
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those standards. From analyzing the flaws in 
the Tuskegee study as well as the testimonials 
of experts and non-experts, I have narrowed 
down a few crucial factors that determine the 
morality of a human experiment. The first is 
that in order for an experiment to be ethical, its 
risks must be justifiable by a potential benefit 
for humanity greater than the risks it imposes 
on the subjects. This should be common sense 
since it is never ethical to harm other people 
for no reason; however, the doctors conducting 
the Tuskegee study seemed to have missed this 
important checkpoint when assessing their 
experiment. In the case of the Tuskegee study, 
the scientific knowledge that could have been 
gained was only for curiosity, as there was 
no intention of coming up with an improved 
cure from the study. Jones’ book puts it well 
with the 12th chapter title: “Nothing Learned 
Will Prevent, Find, or Cure a Single Case.” This 
first qualification for an ethical study is also 
supported by my personal communication 
with peers, who also brought up the point that 
humans should only be tested if it is for the 
greater good of society. Moreover, the Physicians 
Committee for Responsible Medicine also agrees 
that any unnecessary experimentation should 
be avoided, including testing for patents on new 
drugs that are “essentially a copy of an existing 
drug” (3). 
A second requirement for meeting ethical 
Figure 2: Subjects talking 
with study coordinator, Nurse 
Eunice Rivers c. 1970.
Source: Wikimedia Commons 
(Credit: Center for Disease 
Control and Prevention)
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and keep them up to date with current medical 
practices. The government organization should 
not conduct any research itself and should 
remain completely unaffiliated with any 
organization or company that does conduct 
medical research. The reason for this is to ensure 
that the medical research community can have 
an unbiased governing body completely devoted 
to maintaining the ethics of any experiments 
being conducted. History and common sense 
demonstrate that leaving private companies 
or government organizations to regulate their 
own research will not be effective due to the 
immense conflict of interest that self regulation 
creates. Looking back at the Tuskegee Study, 
the PHS attempted to inspect itself by creating 
an ad hoc counsel of its own members to 
determine the flaws of their own study. Due 
to the biases of the members and the potential 
career consequences speaking out would entail, 
no significant progress was made on seeing the 
ethical problems. In modern medical research, 
experiments on humans are required to follow 
the Common Rule, which was made in 1991 and 
“defined human participant research, specified 
the role and scope of informed consent, and 
required research oversight and compliance 
through institutional review boards (IRBs) at 
participating research entities.” In addition, 
many government agencies were formed to help 
regulate human research including the Office 
for Human Research Protections (OHRP). These 
steps that the government has taken in response 
to Tuskegee are good progress; however, there is 
still much room for improvement. For example, 
a current problem with the policy is that it has 
become out of date due to changes in medical 
practices, so a new version of the law has been 
passed and will take effect starting in 2018 (4).
The final step in ensuring that human medical 
research is as ethical as possible is expanding 
the scope of regulation to the public. I believe 
that it is essential for the public to be involved 
as educated observers in order to make sure that 
both private companies as well as government 
regulatory bodies are following ethical protocol. 
In this way, the public serves as an additional 
check on the government organizations. In 
order to ensure that the public gets involved, 
the government agencies must have a high 
level of transparency and must work to spread 
awareness of important ethical issues in human 
research. One way this can be done is by using 
correct terms when describing an experiment. 
In a linguistics article, George Annas points out 
that “Even a cursory examination of modern 
human experimentation demonstrates the 
pervasiveness of three doublespeak concepts: 
experimentation is treatment, researchers are 
physicians, and subjects are patients”(Elliot). 
This demonstrates the power of the language 
used to describe human experiments; in modern 
medical experiments, researchers market their 
human experiment as a study to make it seem 
harmless, as the term “study” has a much less 
serious connotation than “human experiment” 
does. In this way, researchers are able to deceive 
many people into participating since they 
overlook the risks once they have perceived it 
as a harmless study.
Possible objections to the need for strong 
regulation of an ethical standard in human 
medical research include its questionable 
practicality and whether regulation will be able 
to keep up with changes in medical practices. The 
first objection is reasonable since government 
agencies are not infallible and do have a chance 
of falling to corruption and bribery by large 
pharmaceutical companies. In order to mitigate 
this risk, these regulatory government agencies 
should be very open to the public about their 
actions in order to allow the general population 
to act as a check and balance. Another objection 
stems from the possibility of companies 
outsourcing human experimentation to overseas 
outside of U.S. regulatory bodies’ jurisdiction. 
For this reason, I think it is important to add 
informed consent on human experimentation to 
the list of basic human rights that the United 
Nations protects in order to have international 
compliance with ethical standards. Finally, there 
is the issue of changes in medical practices due 
to accelerating globalization and technological 
growth outpacing regulation. This concern is 
valid and is a major problem across all types 
of government regulation. The best solution to 
this would be to adhere to the general principles 
of ethics at all times so that even when specific 
regulation laws become obsolete due to new 
procedures and technology, experimentation is 
still bound by the basic foundation of ethics.
The importance of regulation on human 
medical experiments is incontrovertible due 
to the story that the history tells us of the 
consequences of unregulated or under-regulated 
human experimentation. If adequate regulation 
is not implemented, repeats of Tuskegee, 
chemical weapons tests, radiation tests, AIDS 
placebo tests, and many more of the type are 
certain to occur. Therefore, it is important to set 
up the rules in such a way that pharmaceutical 
companies are incentivized to conduct only 
ethical research with the informed consent 
of the subjects and the potential benefits to 
humanity in mind. In order to implement 
these rules, a new government organization 
should be created with the purpose of keeping 
experiments in check legally. This organization 
would differ from current organizations since it 
would be connected to the legal department and 
be overseen by the attorney general. This would 
ensure that this regulatory organization will have 
“It is important to 
set up the rules 
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legal jurisdiction to enforce federal regulations 
at any time during the study. This is opposed 
to the current Institutional Review Boards that 
are in place and only determine if a study can 
begin according to the guidelines set by the 
institution. A federal legal organization could 
also conduct random reviews mid-experiment 
for a certain percent of human experiments 
conducted in the country. The reason this is an 
important improvement from IRBs is because 
oftentimes a study will change its course as 
it goes on, escaping the regulation of IRBs, 
which only check the study at its inception. A 
recent example of this is the Polyheme testing, 
which was a test for a substitute for blood 
transfusions during emergency situations. The 
study started out by following informed consent 
standards; however, this changed as the study 
went on. An article on the ethics of this study 
states, “Trialing the product in an emergency 
medical services setting, though, would require 
using waivers of consent under the 1996 FDA 
rule”(5). In this situation, Polyheme changed 
the course of their study and in the process, 
lost the informed consent that was originally 
part of the study and cost the lives of many 
patients who were unwillingly subject to the 
study. While the study was eventually stopped, 
it took a long time to end, and during that 
time, many casualties occurred. To fix this, a 
new government organization that performs 
random reviews on ongoing studies should be 
created. This solution would create incentives 
for companies that sponsor research to stay on 
track with the approved guidelines of the study 
as well as terminate any studies that start being 
unethical early in order to minimize casualties.
From the chart below (Figure 3), it is evident 
that Polyheme resulted in more deaths than the 
control during the two days for which data was 
provided. Many of these unnecessary deaths 
may be avoided if a government organization 
conducting random reviews on ongoing 
research could cut the study short. 
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